Showing results (141-150 of 152) with videos related to
Sort By:
Pageof 16
Cancer Chemotherapy and Pharmacology|January 1, 1990
Inflammatory carcinoma of the breast: results of a combined-modality approach--M.D. Anderson Cancer Center experienceE H Koh, A U Buzdar, F C Ames, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1987
Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: a prospective randomized studyG N Hortobagyi, G P Bodey, A U Buzdar, et al.Journal of the National Cancer Institute. Monographs|January 1, 1993
The M. D. Anderson Cancer Center experience with Taxol in metastatic breast cancerF A Holmes, V Valero, R S Walters, et al.Physical Review Letters|April 30, 2021
Collisions between Ultracold Molecules and Atoms in a Magnetic TrapS Jurgilas, A Chakraborty, C J H Rich, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: phase I resultsF A Holmes, V Valero, R S Walters, et al.The Journal of Pharmacology and Experimental Therapeutics|May 1, 1983
Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studiesC B Nemeroff, D Luttinger, D E Hernandez, et al.Cancer Chemotherapy and Pharmacology|January 1, 1997
Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer CenterN T Ueno, A U Buzdar, S E Singletary, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experienceR A Brito, V Valero, A U Buzdar, et al.Proceedings of the National Academy of Sciences of the United States of America|July 26, 2022
A missense mutation in Kcnc3 causes hippocampal learning deficits in micePin Xu, Kazuhiro Shimomura, Changhoon Lee, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 13, 2007
Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancersC Mazouni, S-W Kau, D Frye, et al.Pageof 16